Robert D. Ciappenelli, Chief Commercial Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 30,000 shares at $35.00 ($1.1M) on 2021-06-11, disclosed to the SEC on 2021-06-15.
Open-market sale of $1.1M DRNA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 10,000 | $350K | 31.5% |
| 2 | $38.00 | 20,000 | $760K | 68.5% |
| Total | $37.00 avg | 30,000 | $1.1M | 100% |